awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38214511-6F284220-C454-4F87-A7B1-9816BECC532D
Q38214511-6F284220-C454-4F87-A7B1-9816BECC532D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38214511-6F284220-C454-4F87-A7B1-9816BECC532D
Antibodies directed against receptor tyrosine kinases: current and future strategies to fight cancer.
P2860
Q38214511-6F284220-C454-4F87-A7B1-9816BECC532D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38214511-6F284220-C454-4F87-A7B1-9816BECC532D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4e5214cb3e5955f018ebf6669abc68de293a0371
P2860
Tanibirumab (TTAC-0001): a fully human monoclonal antibody targets vascular endothelial growth factor receptor 2 (VEGFR-2).